HOG
29
4
FITB
36
3
NTAP
58
3
VRSK
54
2
R
55
-2
ROST
60
3
BXP
39
5
CAG
34
3
DE
49
3
EBAY
42
2
MET
58
2
DG
14
6
RF
44
10
GOOGL
62
6
PEG
53
7
OXY
42
17
AZO
46
3
PYPL
49
4
MO
47
6
PRU
39
3
HOG
29
4
FITB
36
3
NTAP
58
3
VRSK
54
2
R
55
-2
ROST
60
3
BXP
39
5
CAG
34
3
DE
49
3
EBAY
42
2
MET
58
2
DG
14
6
RF
44
10
GOOGL
62
6
PEG
53
7
OXY
42
17
AZO
46
3
PYPL
49
4
MO
47
6
PRU
39
3
Financhill
Back

Entrada Therapeutics Stock Predictions

Trump's Legacy-Defining Momentor Strike

But the Surprising Way Trump Solves it Could Cement His Legacy.
Sell
37

TRDA
Entrada Therapeutics

Last Price:
$17.60
Seasonality Move:
-24.47%

7 Day Trial

ALL ACCESS PASS

$ 7

The AI Energy Miracle

Details Here.

Entrada Therapeutics Stock Forecast

  • Over the next 52 weeks, Entrada Therapeutics has on average historically risen by 11% based on the past 3 years of stock performance.
  • Entrada Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Entrada Therapeutics Stock Undervalued?
    The current Entrada Therapeutics [TRDA] share price is $17.60. The Score for TRDA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • TRDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Entrada Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Entrada Therapeutics has on average historically risen by 11% based on the past 3 years of stock performance.

Entrada Therapeutics Stock Rating

Sell
37
Entrada Therapeutics (TRDA) is a Sell

Is Entrada Therapeutics overpriced?

  • Entrada Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Entrada Therapeutics Stock Price History

Is TRDA stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
entradatx.com

52-Week Data

52-Week High:
21.79
52-Week Low:
11.35

Prediction Charts

Market Cap:
658.6M
Price in USD:
17.60
Volume:
357.3K
Beta:
-0.18

Technical Analysis

SMA50:
18.48
SMA100:
17.04
SMA200:
15.77
52-Wk Change:
17.41%

Stock Predictions

  • Is Entrada Therapeutics stock public?
    Yes, Entrada Therapeutics is a publicly traded company.
  • What is the Entrada Therapeutics stock quote today?
    The Entrada Therapeutics stock price is 17.60 USD today.
  • How to buy Entrada Therapeutics stock online?
    You can buy Entrada Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 20.32 20.17 20.50 19.98
Dec-4 20.18 19.96 20.26 19.60
Dec-5 19.90 20.32 20.46 19.58
Dec-6 20.81 21.59 21.63 20.48
Dec-9 21.75 21.52 21.79 21.19
Dec-10 21.37 20.51 21.46 20.37
Dec-11 20.53 19.90 21.08 19.86
Dec-12 19.74 18.12 19.93 18.05
Dec-13 17.93 17.66 17.93 17.26
Dec-16 17.61 18.01 18.46 17.28
Dec-17 17.89 18.45 18.54 17.83
Dec-18 18.50 17.11 18.96 17.00
Dec-19 17.11 17.28 17.68 16.86
Dec-20 16.86 17.60 18.00 16.86

Entrada Therapeutics Earnings

Entrada Therapeutics Earnings Report: Per Share Entrada Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Entrada Therapeutics Forecast Revenue Growth

Entrada Therapeutics Stock Analysis: Historical quarterly revenues per share for Entrada Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and a decrease next year of $4.09 per share.

* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.